According to a new report, published by KBV research, The Global Bioinformatics Market size is expected to reach $19.9 billion by 2028, rising at a market growth of 12.5% CAGR during the forecast period.
The Bioinformatics Services market would witness a CAGR of 13.2% during (2022 - 2028). Growing R&D activities and an increase in the need for new medications are two reasons driving the growth of the Bioinformatics Market. Additionally, the demand for bioinformatics services is rising in the worldwide market as a consequence of technical improvements.
The Medical Biotechnology market is leading the Global Bioinformatics Market by Sector in 2021; thereby, achieving a market value of $9.0 Billion by 2028. Additionally, from 2022 to 2028, the same category is anticipated to have the highest growth rate. Medical bioinformatics assists in the reduction of mistakes that may happen with conventional sequencing techniques and enhances the effectiveness of sequencing operations. These services are useful for agrigenomics, human illnesses, animals, and microorganisms.
The Chemoinformatics & Drug Design market would showcase a CAGR of 13.2% during (2022 - 2028). Genetics is now one of medicine's most active fields, and genetic information is crucial to all branches of medicine. Although the tools used to evaluate the data created by genomics are likely similar to those utilized by physicists and engineers who research financial markets and fiber optics, doing a meaningful analysis of the data requires a thorough understanding of biology. As a result, bioinformatics evolved to become a crucial hybrid area of study.
The North America market dominated the Global Bioinformatics Market by Region in 2021; thereby, achieving a market value of $8.2 Billion by 2028. The Europe market is poised to grow at a CAGR of 12.3% during (2022 - 2028). Additionally, The Asia Pacific market would exhibit CAGR of 13.7% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/bioinformatics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Waters Corporation, PerkinElmer Inc., Genedata AG, Neogenomics laboratories, BGI Group
By Product & Services
By Sector
By Application
By Geography
Companies Profiled
Unique Offerings 
